US8816242098 - ADR
TEVA PHARMACEUTICAL-SP ADR
NYSE:TEVA (7/26/2024, 7:04:00 PM)
After market: 17.1 0 (0%)17.1
+0.3 (+1.79%)
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. The firm operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
TEVA PHARMACEUTICAL-SP ADR
124 Dvora Hanevi'a St
TEL AVIV-YAFO 49131
P: 97239148213
CEO: Kare Schultz
Employees: 35001
Website: https://www.tevapharm.com/
A modest amount of money can go a long way on Wall Street when it's put to work in innovation-driven businesses.
On Friday, Dr. Reddy's Labs ADR stock earned an upgrade to its Relative Strength (RS) Rating, from 66 to 76.
Here you can normally see the latest stock twits on TEVA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: